KR910007923A - 3-(l-피로글루타밀)-l-티아졸리딘-4-카르복실산과 그 유도체의 제조방법 - Google Patents
3-(l-피로글루타밀)-l-티아졸리딘-4-카르복실산과 그 유도체의 제조방법 Download PDFInfo
- Publication number
- KR910007923A KR910007923A KR1019900015999A KR900015999A KR910007923A KR 910007923 A KR910007923 A KR 910007923A KR 1019900015999 A KR1019900015999 A KR 1019900015999A KR 900015999 A KR900015999 A KR 900015999A KR 910007923 A KR910007923 A KR 910007923A
- Authority
- KR
- South Korea
- Prior art keywords
- pyroglutamyl
- derivatives
- thiazolidine
- preparing
- carboxylic acid
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims 4
- -1 L-pyroglutamyl Chemical group 0.000 title claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 125000003710 aryl alkyl group Chemical group 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000005099 aryl alkyl carbonyl group Chemical group 0.000 claims 1
- 125000005129 aryl carbonyl group Chemical group 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 claims 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 125000003107 substituted aryl group Chemical group 0.000 claims 1
- 125000004665 trialkylsilyl group Chemical group 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06173—Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (4)
- 하기식(I)의 화합물을 하기식(II)의 화합물과 반응시킴으로써 3-(L-피로글루타밀)-L-타이졸리딘-4-카르복실산과 그 유도체를 제조하는 방법.상기식에서 R1은 수소, C1-C6알킬, C3-C7시클로알킬, C4-C10시클로알킬알킬, 아릴과 치환된 아릴, C2-C5알콕시 카르보닐, C2-C10일킬카르보닐, 아릴카르보닐과 아르알킬카르보닐, C8-C13아르알콕시카르보닐과 치환된 아르알콕시카르보닐이고, X는 OH, OR2(R2는 활성기) 또는 C1고 R3는 수소 또는 C3-C9트리알킬실릴이다.
- 제1항에 있어서, R2는 C4-C8알킬, C4-C10시클로알킬, 아릴, 치환된 아릴, C2-5알콕시카르보닐, C7-C12아르알킬이나 치환된 아르알킬, 디클로로포스포릴로 구성되는 그룹으로 부터 선택되는 제조방법.
- 제1항에 있어서, X가 OH일때, 반응이 축합제 존재하에서 수행되는 제조방법.
- 제3항에 있어서, 축합제는 디시클로헥실카보디이미드와 카르보닐디이미다졸로 구성되는 그룹으로 부터 선택되는 제조방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT22003A IT1239029B (it) | 1989-10-12 | 1989-10-12 | Processo per la preparazione dell'acido 3-(l-piroglutamil)-l- tiazolidin-4-carbossilico e suoi derivati. |
IT22003/89 | 1989-10-12 | ||
IT22003/87 | 1989-10-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR910007923A true KR910007923A (ko) | 1991-05-30 |
KR100195895B1 KR100195895B1 (ko) | 1999-06-15 |
Family
ID=11190043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019900015999A KR100195895B1 (ko) | 1989-10-12 | 1990-10-10 | 3-(l-피로글루타밀)-l-티아졸리딘-4-카르복실산 및 그 유도체의 제조방법) |
Country Status (18)
Country | Link |
---|---|
US (1) | US5110936A (ko) |
EP (1) | EP0422566B1 (ko) |
JP (1) | JP2813450B2 (ko) |
KR (1) | KR100195895B1 (ko) |
AT (1) | ATE121420T1 (ko) |
AU (1) | AU644379B2 (ko) |
CA (1) | CA2027341C (ko) |
DE (2) | DE422566T1 (ko) |
DK (1) | DK0422566T3 (ko) |
ES (1) | ES2028766T3 (ko) |
FI (1) | FI95271C (ko) |
GR (1) | GR910300072T1 (ko) |
HU (1) | HU210213B (ko) |
IE (1) | IE67047B1 (ko) |
IL (1) | IL95949A (ko) |
IT (1) | IT1239029B (ko) |
NO (1) | NO178028C (ko) |
ZA (1) | ZA908097B (ko) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1230706B (it) * | 1989-02-10 | 1991-10-29 | Poli Ind Chimica Spa | Derivati dell'acido 3 piroglutamoil tiazolidin 4 carbossilico e loro proprieta' farmacologiche. |
IT1237998B (it) * | 1990-01-23 | 1993-06-21 | Poli Ind Chimica Spa | Acido 3-l-(5-tioxo-l-prolil)tiazolidin-4-carbossilico e derivati, loro preparazione e composizioni farmaceutiche che li contengono |
IT1270017B (it) * | 1994-09-27 | 1997-04-16 | Poli Ind Chimica Spa | "sintesi quantitativa dell'acido 3-(l-piroglutamil)-l-tiazolidin-4- carbossilico e suoi derivati" |
AU4335297A (en) * | 1996-09-06 | 1998-03-26 | Eli Lilly And Company | Process and novel intermediates |
US8404804B2 (en) * | 2007-08-28 | 2013-03-26 | Ipsen Pharma S.A.S. | Methods and intermediates for chemical synthesis of polypeptides and proteins |
CN102167727B (zh) * | 2011-01-29 | 2013-05-15 | 浙江金立源药业有限公司 | 一种匹多莫德的合成方法 |
WO2016112977A1 (en) | 2015-01-15 | 2016-07-21 | Polichem S.A. | Di-pidotimod benzathine and solid forms thereof |
KR101642445B1 (ko) * | 2016-01-11 | 2016-07-26 | (주)남양통신 | 수상태양광 발전장치용 계류장치 |
CN107383162A (zh) * | 2017-07-06 | 2017-11-24 | 成都美域高制药有限公司 | 一种匹多莫德的制备方法 |
CN108640912A (zh) * | 2018-06-19 | 2018-10-12 | 广州大光制药有限公司 | 一种匹多莫德的工业化规模制备方法 |
CN111233854A (zh) * | 2019-12-30 | 2020-06-05 | 常州寅盛药业有限公司 | 一种匹多莫德杂质的制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1202426B (it) * | 1987-01-26 | 1989-02-09 | Poli Ind Chimica Spa | Derivato di acido tiazolidin-4-carbossilico,sua preparazione e composizioni farmaceutiche che lo contengono |
-
1989
- 1989-10-12 IT IT22003A patent/IT1239029B/it active IP Right Grant
-
1990
- 1990-10-08 ES ES90119271T patent/ES2028766T3/es not_active Expired - Lifetime
- 1990-10-08 DE DE199090119271T patent/DE422566T1/de active Pending
- 1990-10-08 DE DE69018755T patent/DE69018755T2/de not_active Expired - Fee Related
- 1990-10-08 DK DK90119271.6T patent/DK0422566T3/da active
- 1990-10-08 AT AT90119271T patent/ATE121420T1/de not_active IP Right Cessation
- 1990-10-08 EP EP90119271A patent/EP0422566B1/en not_active Expired - Lifetime
- 1990-10-08 IE IE359990A patent/IE67047B1/en not_active IP Right Cessation
- 1990-10-09 US US07/594,313 patent/US5110936A/en not_active Expired - Lifetime
- 1990-10-09 ZA ZA908097A patent/ZA908097B/xx unknown
- 1990-10-10 KR KR1019900015999A patent/KR100195895B1/ko not_active IP Right Cessation
- 1990-10-10 IL IL9594990A patent/IL95949A/en not_active IP Right Cessation
- 1990-10-11 AU AU64521/90A patent/AU644379B2/en not_active Ceased
- 1990-10-11 NO NO904404A patent/NO178028C/no unknown
- 1990-10-11 HU HU906417A patent/HU210213B/hu not_active IP Right Cessation
- 1990-10-11 CA CA002027341A patent/CA2027341C/en not_active Expired - Fee Related
- 1990-10-11 FI FI905011A patent/FI95271C/fi active IP Right Grant
- 1990-10-12 JP JP2275100A patent/JP2813450B2/ja not_active Expired - Fee Related
-
1991
- 1991-11-15 GR GR91300072T patent/GR910300072T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR850003402A (ko) | 2-아미노-5-하이드록시-4-메틸 피리미딘 유도체의 제조방법 | |
DE2962643D1 (en) | 3,5-dihydroxypentanoic ester derivatives having antihyperlipaemic activity, their manufacture and pharmaceutical compositions containing them | |
KR910007923A (ko) | 3-(l-피로글루타밀)-l-티아졸리딘-4-카르복실산과 그 유도체의 제조방법 | |
KR860000243A (ko) | 아민유도체의 제조방법 | |
KR840005464A (ko) | 포스포리피드 유도체의 제조방법 | |
KR830007550A (ko) | 시클릭아민의 제조방법 | |
KR840003615A (ko) | 피리딘 화합물의 제조방법 | |
ATE116991T1 (de) | Semisynthetische rhodomycine, verfahren zu ihrer herstellung und ihre verwendung als zytostatika. | |
KR840002766A (ko) | 디플루니잘 및 관현 화합물의 1-(알콕시 또는 아르옥시) 카보닐옥시알킬 에스테르의 제조방법 | |
EP0371875A3 (en) | Process for preparing 4-acetoxyazetidinones | |
KR840001165A (ko) | 시드논 이민 유도체의 제조방법 | |
KR840005815A (ko) | I-옥사세팜 화합물의 제조방법 | |
ATE277051T1 (de) | Verfahren zur herstellung von debromohymenialdisin und deren analogen | |
KR850003407A (ko) | 유기인산 에스테르 유도체의 제조방법 | |
GB1302823A (ko) | ||
KR890005027A (ko) | 페녹시알킬카복실산 유도체 및 그의 제조방법 | |
KR840004721A (ko) | 5-옥소(oxo)-2-피롤리딘프로파노인산 유도체의 제조방법 | |
KR880001635A (ko) | 5-플루오로우라실 유도체, 그의 제조방법 및 용도 | |
KR850007800A (ko) | 세팔로스포린 유도체의 에스테르 제조방법 | |
DE59008715D1 (de) | 2-Formylbenzylphosphonsäure-Derivate, deren Herstellung und ihre Verwendung zur Behandlung von durch Viren verursachte Krankheiten. | |
KR840002774A (ko) | 플루오로페녹시벤질 에스테르류의 제조방법 | |
KR850007064A (ko) | 0.0-디메틸디티오포스포릴페닐 아세트산의 안정화 방법 | |
KR840003633A (ko) | 피리미돈 화합물의 제조방법 | |
KR910007914A (ko) | 벤즈이미다졸 유도체의 신규한 제조방법 | |
KR830002746A (ko) | 테트라 히드로프탈 아미드 유도체의 제조방법 및 제초조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20100216 Year of fee payment: 12 |
|
EXPY | Expiration of term |